Medicare Enrolled
Dr. Alon Steinberg, MD
Cardiovascular Disease · Ventura, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Steinberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steinberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Steinberg
Dr. Alon Steinberg is a cardiovascular disease specialist in Ventura, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Steinberg performed 5,465 Medicare services across 3,499 unique beneficiaries.
Between the years covered by Open Payments, Dr. Steinberg received a total of $57,318 from 52 pharmaceutical and/or device companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Steinberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in CA
$57,318 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,465
Medicare services
Top 16% in CA for cardiovascular disease
3,499
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,048 | $43 | $166 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
751 | $102 | $397 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
502 | $12 | $47 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
421 | $169 | $664 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
330 | $44 | $365 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
315 | $54 | $198 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 232 | $417 | $1,200 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
194 | $41 | $151 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
187 | $118 | $437 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
165 | $412 | $1,508 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
151 | $4 | $15 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
128 | $11 | $42 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
128 | $22 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
107 | $140 | $562 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
97 | $46 | $178 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $66 | $281 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
67 | $1,723 | $6,540 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
66 | $124 | $468 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
50 | $1,373 | $5,145 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $64 | $244 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
36 | $6 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
36 | $145 | $535 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
31 | $47 | $171 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
31 | $22 | $81 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
31 | $203 | $781 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
27 | $21 | $78 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $101 | $367 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
25 | $89 | $326 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
24 | $12 | $43 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
23 | $18 | $65 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
18 | $11 | $42 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
18 | $19 | $72 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
18 | $24 | $162 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
17 | $21 | $76 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
15 | $67 | $255 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $76 | $295 |
| New patient office visit, complex (60-74 min) | 13 | $150 | $697 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.6% high complexity
33.1% medium
56.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$57,318
Total received (2018-2024)
Avg $8,188/year across 7 years
Top 9% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
785
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$40,417 (70.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,852 (20.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,048 (8.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,879
2023
$2,173
2022
$1,586
2021
$1,510
2020
$1,641
2019
$18,121
2018
$30,407
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$324
Kiniksa Pharmaceuticals International, plc
$223
Amgen Inc.
$188
Boston Scientific Corporation
$157
Merck Sharp & Dohme LLC
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
E.R. Squibb & Sons, L.L.C.
$113
PFIZER INC.
$104
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$86
AstraZeneca Pharmaceuticals LP
$81
Impulse Dynamics (USA) Inc.
$78
Lexicon Pharmaceuticals, Inc.
$72
Alnylam Pharmaceuticals Inc.
$48
Abbott Laboratories
$36
Janssen Pharmaceuticals, Inc
$36
CVRx, Inc.
$24
Esperion Therapeutics, Inc.
$18
SCPHARMACEUTICALS INC.
$18
Novo Nordisk Inc
$15
BIOTRONIK INC.
$14
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$25,950
Novartis Pharmaceuticals Corporation
$13,692
Boston Scientific Corporation
$7,917
Amgen Inc.
$1,518
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,069
PFIZER INC.
$724
ABIOMED
$635
E.R. Squibb & Sons, L.L.C.
$565
Boehringer Ingelheim Pharmaceuticals, Inc.
$535
AstraZeneca Pharmaceuticals LP
$495
Gilead Sciences, Inc.
$344
SANOFI-AVENTIS U.S. LLC
$314
Abbott Laboratories
$293
Merck Sharp & Dohme LLC
$274
Kiniksa Pharmaceuticals International, plc
$223
Amarin Pharma Inc.
$183
BIOTRONIK INC.
$167
Merck Sharp & Dohme Corporation
$161
Alnylam Pharmaceuticals Inc.
$155
Kowa Pharmaceuticals America, Inc.
$150
Esperion Therapeutics, Inc.
$145
Regeneron Healthcare Solutions, Inc.
$135
CVRx, Inc.
$130
Astellas Pharma US Inc
$130
Medtronic, Inc.
$125
Edwards Lifesciences Corporation
$123
iRhythm Technologies, Inc.
$119
Kiniksa Pharmaceuticals, Ltd.
$93
Actelion Pharmaceuticals US, Inc.
$90
Impulse Dynamics (USA) Inc.
$78
Lexicon Pharmaceuticals, Inc.
$72
ATRICURE, INC.
$70
Allergan Inc.
$63
Biosense Webster, Inc.
$59
Baxter Healthcare
$56
ACIST MEDICAL SYSTEMS, INC.
$56
Alexion Pharmaceuticals, Inc.
$48
Otsuka America Pharmaceutical, Inc.
$43
Medtronic Vascular, Inc.
$37
Braemar Manufacturing, LLC
$33
BOSTON SCIENTIFIC CORPORATION
$30
Novo Nordisk Inc
$30
Lundbeck LLC
$25
CARDIVA MEDICAL, INC.
$23
AtriCure, Inc.
$22
CathWorks, Inc.
$21
SCPHARMACEUTICALS INC.
$18
ARBOR PHARMACEUTICALS, INC.
$18
HeartFlow, Inc.
$17
G Medical Diagnostic Services, Inc.
$16
Amicus Therapeutics, Inc.
$16
Phadia US Inc.
$13
Top 3 companies account for 83.0% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ATRICURE ATRICLIP LAA EXCLUSION · AVEIR · Acticor 7 VR-T DX · Arcalyst · BIOMONITOR · BRILINTA · BYDUREON · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARTO 3 · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Carto 3 System · Confirm Rx · CoreValve Evolut · Corlanor · Durata Defibrillation ICD Lead · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRangio System · FFRct · FUROSCIX · GALLANT · GENERAL - TACHY · Hillrom - Cardiac Ambulatory Monitor · INVOKANA · ImmunoCAP · Impella · Inpefa · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Optimizer · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · REVEAL LINQ · RXI CONSUMABLES · Repatha · Rybelsus · SAMSCA · Selectra · THERAPIES · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Device · Victoza · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
39
Per 100K population
4.7
County median income
$107,327
Nearest hospital
VENTURA COUNTY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Steinberg is a cardiac imaging specialist, with above-average Medicare volume (top 16% in CA), with speaking/promotional industry engagement in the top 9% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Steinberg experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Steinberg performed 1,048 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Steinberg receive payments from pharmaceutical companies?
Yes. Dr. Steinberg received a total of $57,318 from 52 companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Steinberg's costs compare to other cardiologists in Ventura?
Dr. Steinberg's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Steinberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Ventura
Browse cardiologists in Ventura ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology